249 related articles for article (PubMed ID: 10497846)
1. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
[TBL] [Abstract][Full Text] [Related]
2. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
3. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
4. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
Vondrácek J; Sheard MA; Krejcí P; Minksová K; Hofmanová J; Kozubík A
J Leukoc Biol; 2001 May; 69(5):794-802. PubMed ID: 11358989
[TBL] [Abstract][Full Text] [Related]
5. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
8. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
[TBL] [Abstract][Full Text] [Related]
9. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.
Arimura K; Arima N; Matsushita K; Ohtsubo H; Fujiwara H; Kukita T; Ozaki A; Hagiwara T; Hamada H; Yoshino K; Tei C
Eur J Haematol; 2004 Jul; 73(1):17-24. PubMed ID: 15182333
[TBL] [Abstract][Full Text] [Related]
11. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
Gil J; Esteban M
Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
[TBL] [Abstract][Full Text] [Related]
13. Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes.
Allampallam K; Shetty V; Hussaini S; Mazzoran L; Zorat F; Huang R; Raza A
Anticancer Res; 1999; 19(6B):5323-8. PubMed ID: 10697556
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes.
Mundle SD; Reza S; Ali A; Mativi Y; Shetty V; Venugopal P; Gregory SA; Raza A
Cancer Lett; 1999 Jun; 140(1-2):201-7. PubMed ID: 10403560
[TBL] [Abstract][Full Text] [Related]
15. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
[TBL] [Abstract][Full Text] [Related]
16. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
[TBL] [Abstract][Full Text] [Related]
17. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.
Orazi A; Kahsai M; John K; Neiman RS
Mod Pathol; 1996 Jan; 9(1):48-52. PubMed ID: 8821956
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells.
Zhou YW; Komada Y; Inaba H; Azuma E; Sakurai M
Cell Immunol; 1998 Jun; 186(2):103-10. PubMed ID: 9665752
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
20. Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
Benesch M; Platzbecker U; Ward J; Deeg HJ; Leisenring W
Leukemia; 2003 Dec; 17(12):2460-6. PubMed ID: 14562111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
